VEL-101 to Prevent Rejection After Kidney Transplantation

Clinical trial NCT07290777 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07290777
Sponsor: Veloxis Pharmaceuticals
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Transplantation, Kidney

Start date: 2026-07-01
Primary completion: 2028-10-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.